Biocon is currently trading at Rs. 386.80, down by 12.30 points or 3.08% from its previous closing of Rs. 399.10 on the BSE.
The scrip opened at Rs. 373.80 and has touched a high and low of Rs. 389.70 and Rs. 371.70 respectively. So far 3,82,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 424.15 on 19-Jul-2017 and a 52 week low of Rs. 255.41 on 12-Aug-2016.
Last one week high and low of the scrip stood at Rs. 408.20 and Rs. 371.70 respectively. The current market cap of the company is Rs. 23,208.00 crore.
The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 18.80% and 20.53% respectively.
The company has reported a fall of 61.46% in its net profit at Rs 54.50 crore for first quarter ended June 30, 2017 as compared to Rs 141.40 crore for the same quarter in the previous year. Total income of the company decreased 17.43% at Rs 606.70 crore for Q1FY18 as compared to Rs 734.80 crore for the corresponding quarter previous year.
On consolidate basis, the company has reported a fall of 51.20% in its net profit at Rs 81.30 crore for the quarter ended June 30, 2017 as compared to Rs 166.60 crore for the corresponding quarter in the FY17. Total consolidated income of the company decreased by 4.38% at Rs 987.70 crore for quarter under review as compared to Rs 1032.90 crore for the same quarter in the previous year.